[HTML][HTML] Targeting the latent reservoir for HIV-1

S Sengupta, RF Siliciano - Immunity, 2018 - cell.com
Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse
immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within …

Targeting the Latent Reservoir for HIV-1.

S Sengupta, RF Siliciano - Immunity, 2018 - europepmc.org
Antiretroviral therapy can effectively block HIV-1 viral replication and prevent or reverse
immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within …

[引用][C] Targeting the Latent Reservoir for HIV-1

S Sengupta, RF Siliciano - Immunity, 2018 - cir.nii.ac.jp
Targeting the Latent Reservoir for HIV-1 | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …

Targeting the Latent Reservoir for HIV-1

S Sengupta, RF Siliciano - Immunity, 2018 - pubmed.ncbi.nlm.nih.gov
Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse
immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within …

[HTML][HTML] Targeting the Latent Reservoir for HIV-1

S Sengupta, RF Siliciano - Immunity, 2018 - Elsevier
Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse
immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within …

Targeting the Latent Reservoir for HIV-1

S Sengupta, RF Siliciano - Immunity, 2018 - pure.johnshopkins.edu
Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse
immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within …

[HTML][HTML] Targeting the latent reservoir for HIV-1

S Sengupta, RF Siliciano - Immunity, 2018 - ncbi.nlm.nih.gov
Antiretroviral therapy can effectively block HIV-1 viral replication and prevent or reverse
immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within …